Business

mass. movers

Alkermes cites positive results

A self-help psychological course in London.

Associated Press/File 2013

A self-help psychological course in London.

Advertisement

Alkermes PLC reported data that suggest its drug for major depressive disorder in patients who don’t respond well to standard therapies will work. ALKS 5461 produced statistically significant improvement on three rating scales, compared to a placebo. A press release said ALKS 5461 reflects a new approach “based on modulation of opioid receptors in the brain and is designed as a non-addictive, oral, once-daily medicine.” Based in Ireland, Alkermes has a research center in Waltham.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com